Neuralink’s 2022 Show & Tell is about to begin. The event is supposed to update the public on Neuralink’s progress and attract talent to the company.
Teslarati will be closely following the event. Please refresh this page for the latest coverage.
Tesla CEO Elon Musk recently posted about the event and hinted at an exciting update on Neuralink.
In the intro video of Neuralink’s Show and Tell event, Pager the monkey seems to be learning to type words with his mind.
Elon Musk enters the stage and welcomes everyone to the event. Wasting no time at all, Musk dives into Neuralink’s Show and Tell, starting with the company’s goals. Neuralink’s goal is to make a generalized I/O interface for the brain that could help people with debilitating conditions.
Musk hints that some of the topics covered during the event will reach an esoteric level. He reaffirms that Neuralink is confident that its device will help people suffering with brain injuries along the way to bridging the gap between computers and the human brain.
“We are confident that this point we will succeed at solving many brain injury issues spine injury issues along the way,” he said.
Musk shows a video of Pager playing “Monkey Mind Pong.” The video was released about 18 months ago. The Tesla CEO emphasizes that Neuralink’s device is not outwardly obvious to others.
Pager initially learned to play Pong with a joystick. Neuralink later took the joystick away and had Pager play Pong with his mind though Neuralink’s device.
Human Trials
Musk reminds the audience that going from prototype to production is difficult and has many challenges. Neuralink has been working hard to start human trials. The company has submitted all the papers needed to start human trials to the FDA. Musk estimates that the first Neuralink device could be inside the human brain in 5-6 months.
Elon Musk emphasizes that Neuralink treats its animal subjects with respect. The company does extensive benchmark tests before implanting a Neuralink device into an animal.
Another Neuralink monkey, Sake, is typing with his brain. Sake spelled out the Neuralink event’s welcome tag: “Welcome to show and tell.”
Neuralink Upgradeability
Both Sake and Pager have successfully implanted with Neuralink’s upgraded device.
“Upgradeability is very important because our first production device will be much like an iPhone 1 and pretty sure you would not want an iPhone 1 stuck in your head if the iPhone 14 is available,” Elon Musk.
Neuralink Application
Elon Musk says that Neuralink can restore vision, even on someone who was born blind. The company is also confident that the Neuralink device can restore full functionality to a severed spinal cord.
Recruitment
“If you have expertise in creating advanced devices, like watches and computers, then your abilities will be of great use in solving these problems,” Musk said.
Neuralink Implant and Surgical Robot
Elon Musk passes the baton to DJ, who has been at Neuralink since the beginning. DJ talks about creating a high bandwidth generalized interface to the brain. He talks about safety, scalability and access to brain regions, the three pillars to get high bandwidth generalized interface to the brain.
DJ talks about the Neuralink implant (the N1) with thin threads N1 implant is about the size of a quarter. It has 1,024 channels that are capable of recording and stimulating.
He also talks about Neuralink’s surgical robot (the R1 Robot) that will help implant the company’s device into the brain. Neuralink does a live demo of the R1 robot at work with dummy patient Alpha.
Neuralink has a double operating room (OR) in Austin. The company plans to establish its own clinic in the future.
“Neuralink’s been working closely with the FDA to get approval to launch its first clinical human trial in the US hopefully in the next 6 months,” noted DJ.
Neuralink Software
Neuralink has been working on improving cursor speed and accuracy since 2021. The speed and accuracy has improved, but Neuralink is still working on improving it. The company is also working on a mouse and keyboard interfaces to work with Neuralink N1.
Neuralink is training monkeys to write so it can get rid of digital keyboards and increase the typing rate when patients use the N1 implant to write with their minds.
Neuralink N1 Charging
Neuralink has improved the battery of the N1 since its last event. The new charger is uses an Aluminum battery base with 6.78 MHz drive circuit for double the battery life.. Neuralink charges the N1 implant wirelessly.
Neuralink is working on a third generation charger with a bidirectional near field communication.
Neuralink N1 Development
N1 contains a small micro processor. Neuralink conducts hill tests on the N1. Testing became a bottleneck so the team created a new system, allowing it to rapidly test new hardware in the N1 implant, greatly accelerating its development.
Neuralink has developed its own system to rigorously test its implant designs.
R1 Robot Development
Nueralink’s R1 robot will help neurosurgeons implant the N1 chip. As the company continues to improve the R1 robot, it will perform more of the surgery. Neuralink developer, Christine, explained that the R1 robot could make the N1 implant surgery more affordable in the future.
Neuralink Next Generation Application
Dan explains the Neuralink’s potential capability to restore eyesight. Neuralink inserted the N1 into the visual cortex of two monkeys named Code and Dash. By observing Code and Dash, Neuralink can record the receptive fields of their visual fields.
“Our goal will be to turn the lights on for someone who spent decades living in the dark,” said Dan.
After Dan, Joey comes up to talk about Neuralink’s application for people with severed spinal cords. Neuralink has conducted tests showing that it can stimulate movement in animals through multiple implants: the N1 in the brain and implants in the spinal cord.
Elon Musk comes back on stage joined by the Neuralink team to answer questions.
Question Round
Elon Musk states that Neuralink does plan to provide some of its research and technology to research universities and hospitals after receiving FDA approval.
Musk says that Neuralink would consider open-sourcing its data sets. The company could publish them on its website.
Neuralink is working on making the electrode of the N1 implant smaller to prevent scar tissue and inflammation response.
Elon Musk hints that the N1 chip might be able to detect health conditions or monitor people’s health status in the future.
Neuralink is focusing on improving the longevity of the N1 device’s threads at the moment. However, the company appears determined to continue improving the N1 implant with no end date in sight.
Neuralink monkeys adapt and learn to utilize the N1 chip fairly quickly.
“Right now we’re just guessing at a lot about what’s going on in the brain. But if you have direct I/O, there’s no more guessing. What we will learn about the brain with such a device–in wide use–is many orders of magnitude than we currently understand,” Musk said, ending the Neuralink event on that note.
Below is the link to the livestream.
Investor's Corner
Tesla and SpaceX take “Terafab” Trademark fight to Federal Court
Tesla and SpaceX sue a small Illinois firm after cease and desist letters over Terafab.
Tesla and SpaceX are asking a federal judge to rule that their planned Terafab chip factory does not infringe a small Illinois company’s trademark, a request that arrives only after months of quiet negotiation broke down this summer.
The dispute traces to May 18, when Tesla filed three U.S. trademark applications for “Terafab” and “Tesla Terafab,” covering semiconductor chips and related chip making services. TERA-print LLC, a nanotechnology company that has held a federal trademark for “Tera-Fab” since 2021, responded five days later with a cease and desist letter. According to the lawsuit, first reported by Reuters, TERA-print argued that Tesla and SpaceX’s use of “Terafab” would confuse consumers familiar with its own trademark, which covers a desktop photolithography printer sold to researchers for sensor and bioengineering work.
What stands out in the filing is the timing of TERA-print’s own paperwork. One day before sending that cease and desist letter, on May 22, TERA-print applied to expand its existing registration to cover semiconductor materials, silicon chips, nanoelectronic devices and AI design services, categories it had not previously claimed. Tesla and SpaceX call that filing opportunistic in their complaint, noting it arrived two months after Tesla’s public Terafab announcement and just days after Tesla’s own trademark applications went in.
Elon Musk launches TERAFAB: The $25B Tesla-SpaceXAI chip factory that will rewire the AI industry
By June 10, TERA-print was threatening to sue for federal trademark infringement, false designation of origin and unfair competition, the complaint states. Rather than wait to be sued, Tesla, SpaceX and SpaceXAI met with TERA-print six separate times between June and August trying to resolve the dispute directly. Those talks collapsed, and the companies filed for declaratory judgment this week in the U.S. District Court for the Western District of Texas, asking a judge to find that “Terafab” does not infringe TERA-print’s mark before TERA-print can file a claim of its own.
TERA-print isn’t backing down. The company told PCMag it discussed a settlement with Tesla as recently as September 2 and feels misled by what it called Tesla’s professed interest in settling. Its CTO, Andrey Ivankin, said TERA-print holds a Defense Department contract to fabricate semiconductors and partially owns Mattiq Inc., an AI company built on TERA-print’s products, and that the company will vigorously defend its rights.
Tesla and SpaceX argue the overlap is superficial. Terafab is planned as a $16.8 billion complex spanning roughly 100 million square feet at the Grimes County site SpaceX confirmed last month, built to produce chips for Optimus robots, Tesla’s AI computing needs and SpaceX’s orbital data center ambitions, a scale and purpose the companies say no reasonable consumer would confuse with a tabletop lab printer. TERA-print’s product line has stayed focused on lithography tools for biological and sensor research since it registered its mark in 2021.
The trademark fight is the second legal dispute tied to the Terafab project in the past week, following a separate SpaceX suit aimed at keeping company records about the facility out of public view, as KBTX reported. Whether construction proceeds under the Terafab name now depends on a federal judge in Austin.
News
NHTSA just escalated its Tesla Cybercab investigation in a big way
NHTSA escalated its Cybercab audit into a sworn Special Order with a September 30 deadline.
Federal regulators have moved from asking Tesla questions about its Cybercab to demanding sworn answers. The National Highway Traffic Safety Administration issued a Special Order that requires a Tesla officer to sign an affidavit attesting to the completeness of the company’s responses, with a deadline of September 30.
The order builds on Audit Query AQ26002, which NHTSA opened on September 3, the same day Tesla began commercial Cybercab service in Austin. Teslarati covered that initial inquiry when it surfaced, noting the agency wanted to understand how Tesla certified a vehicle with no permanently attached steering wheel, pedals, or mirrors as compliant with Federal Motor Vehicle Safety Standards. A Special Order is a different tool and converts a fact finding review into a legally enforceable demand, the same mechanism NHTSA used against Tesla in 2023 during its Autopilot investigation.
Several of the 21 requests target a specific gap in Cybercab’s design. One asks whether Tesla used temporarily attached human controls at any point to help certify the vehicle, and if so, which standards depended on that equipment being present. Another quotes an existing rule directly: “The service brakes shall be activated by means of a foot control.” Cybercab has no foot pedal. NHTSA wants a detailed explanation of how the vehicle satisfies that requirement, and how it complies without the kind of exemption granted to Zoox in July under Part 555, the regulatory pathway built for steering wheel free vehicles.
The order does not claim Cybercab is unsafe or that Tesla broke a rule. It requires Tesla to explain, under oath, the reasoning behind decisions the company already made when it self-certified the vehicle. That distinction matters, but so does the exposure. Motor1’s reporting, summarized here, put potential civil penalty exposure as high as $139 million if NHTSA later finds the certification was flawed, on top of whatever criminal risk comes with a false sworn statement.
Tesla has not said publicly how it plans to respond. Cybercab is still carrying passengers in Austin through the Robotaxi app while the September 30 deadline approaches, and the company has continued expanding the vehicle’s footprint even as the regulatory question remains open. The Special Order does not pause any of that and just sets a date by which Tesla has to put its certification logic on the record, with a company officer’s name attached to it.
In a new interview on Wednesday, Tesla uber bull Ron Baron said that anyone looking to buy the company’s stock should do so as soon as they can.
Baron, founder and CEO of Baron Capital and one of Tesla’s most persistent institutional bulls, used a CNBC Squawk Box appearance on Wednesday to deliver a familiar message with fresh urgency: In his opinion, Tesla stock is a buy:
“The time to buy the stock is now. FSD is catching on, and it’s going to be bigger and bigger. 55% of new buyers are buying it (Teslas) with FSD. It’s going to be everywhere. It’s safer.”
The Baron Capital frontman’s case is built around Full Self-Driving. Tesla reported 1.48 million active FSD subscriptions in the second quarter, up 56 percent year over year, and company officials have said roughly 55 percent of new North American deliveries left with a subscription enabled.
Baron framed that attach rate as proof the product is moving from enthusiast extra to default expectation, and as a reason software, not just vehicle volume, should drive the next phase of value.
His conviction on Tesla shares is not theoretical, as Baron Capital made its first Tesla investment in 2014, after years of meetings that began around the 2010 IPO roadshow. The firm later built a large SpaceX position starting in 2017.
Ron Baron today in new interview on Tesla:
“The time to buy the stock is now. FSD is catching on, and it’s going to be bigger and bigger. 55% of new buyers are buying it (Teslas) with FSD. It’s going to be everywhere. It’s safer.” pic.twitter.com/Rv5PB0bVZ2
— Sawyer Merritt (@SawyerMerritt) September 16, 2026
Baron said those Musk-led bets have generated about $30 billion of the $71 billion in profits Baron Capital has produced for clients. He put the firm’s current exposure at roughly $25 billion in SpaceX and $5 billion in Tesla. Personally, he described SpaceX as his largest holding, at about $5 billion, with about $1.5 billion in Tesla and additional Tesla exposure through the firm’s funds.
That concentration is also a statement of loyalty. Asked about talk of a SpaceX-Tesla combination, Baron said he had already walked Elon Musk through arguments for and against a deal, then declined to repeat them on air. His public position was simpler: “Whatever you decide is better is what I’m going to support,” he said to Musk.
Baron also said that he picked up the farewell edition of the Model S after Tesla decided to sunset the vehicle earlier this year, calling it his favorite car he’s ever driven.
Tesla and SpaceX take “Terafab” Trademark fight to Federal Court
NHTSA just escalated its Tesla Cybercab investigation in a big way
